Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, August 6, 2024
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
[ Tue, Aug 06th 2024
] - WOPRAI
Emily Bodnar Reiterated (ANAB) at Strong Buy and Held Target at $55 on, Aug 6th, 2024
Emily Bodnar of HC Wainwright & Co., Reiterated "AnaptysBio, Inc." (ANAB) at Strong Buy and Held Target at $55 on, Aug 6th, 2024.
Emily has made no other calls on ANAB in the last 4 months.
There are 4 other peers that have a rating on ANAB. Out of the 4 peers that are also analyzing ANAB, 0 agree with Emily's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Emily
- Anupam Rama of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $69 on, Friday, July 19th, 2024
- David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $34 on, Friday, May 10th, 2024
- David Risinger of "Leerink Partners" Initiated at Buy and Held Target at $47 on, Tuesday, April 16th, 2024
- Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $56 on, Thursday, April 11th, 2024
